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Background: Dysregulated hypothalamic-pituitary-adrenal axis activity and 
dopamine neurotransmission are implicated in mood dysregulation, antidepressant 
efficacy and antidepressant-induced mania. 
Methods: Adrenocorticotropic hormone (ACTH) (100µg/d) was administered 
for 21 days in rat and antidepressant efficacy of imipramine (10mg/kg) was 
assessed in the Open Field Test (OFT) and Forced 
Swim Test (FST) on day 15. Imipramine-resistant animals then received 7 days 
of bilateral nucleus accumbens (NAc) deep brain stimulation (DBS; 130 Hz, 
200µA, 90µSec) followed by OFT and FST. In addition, the effects of NAc DBS 
on ventral tegmental area (VTA) stimulation-evoked NAc dopamine release we 
monitored in ACTH-treated and control rats using fast scan cyclic voltammetry. 
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Results: ACTH pre-treatment blocked imipramine-mediated reductions of 
immobility in the FST (n=10; p<0.05). NAc DBS effectively reduced immobility 
in ACTH-treated animals (n=8; p< 0.05). No significant reduction in immobility 
was observed in sham groups/animals (n=8; p<0.05). Interestingly, a proportion 
(33%; n=5) of the ACTH-treated animals (DBS & Sham) displayed increased 
locomotor activity in the open field test, and exaggerated escape behaviors in the 
FST. Correspondingly, DBS of the NAc significantly potentiated VTA-evoked 
transient NAc dopamine efflux in antidepressant-resistant animals. 
Conclusions: This study demonstrated NAc DBS is an effective antidepressant 
treatment in animals non-responsive to imipramine. Observations of hyperactivity, 
augmented antidepressant response behaviors and potentiated phasic dopamine 
efflux suggest disruption of mesoaccumbens signaling in ACTH-treated animals 
contributing to the development of a mania-like behavior in a subset of vulnerable 
individuals. Further studies are needed to understand mechanisms mediating this 
effect. 
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